• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔人类微生物群成员变形链球菌中次生代谢途径的系统生物合成。

Systems biosynthesis of secondary metabolic pathways within the oral human microbiome member Streptococcus mutans.

作者信息

Zvanych Rostyslav, Lukenda Nikola, Li Xiang, Kim Janice J, Tharmarajah Satheeisha, Magarvey Nathan A

机构信息

Department Chemistry & Chemical Biology, McMaster University, M.G. DeGroote Institute for Infectious Disease Research, 1200 Main St. W, Hamilton, Ontario L8N 3Z5, Canada.

出版信息

Mol Biosyst. 2015 Jan;11(1):97-104. doi: 10.1039/c4mb00406j. Epub 2014 Sep 11.

DOI:10.1039/c4mb00406j
PMID:25209237
Abstract

Streptococcus mutans, a Gram-positive human commensal and pathogen, is commonly recognized as a primary causative agent in dental caries. Metabolic activity of this strain results in the creation of acids and secreted products are recognized as pathogenic factors and agents that promote immunomodulation by stimulating the release of pro-inflammatory cytokines. Products of secondary metabolic pathways of microorganisms from the human microbiome are increasingly investigated for their immunomodulatory functions. In this study, we sought to explore the metabolomic output of nonribosomal peptide pathways within the model S. mutans strain, S. mutans UA159, using a systems metabolomic approach to gain in-depth analysis on products created by this organism and probe these molecules for their immunomodulatory function. Comparative metabolomics and biosynthetic studies using wild-type and nonribosomal peptide deletion strains (within the mutanobactin biosynthetic locus), precursor feedings (fatty acid derivatives) led to the identification of 58 metabolites, 13 of which were structurally elucidated. In addition to these, an assembly line derailment product, mutanamide, was also identified and used to assess immunomodulatory properties of mutanobactins and actions relating to their previously reported functions describing hyphal inhibitory profiles in Candida albicans. The results of this study demonstrate both the complexity and the divergent roles of products stemming from this unique biosynthetic assembly line.

摘要

变形链球菌是一种革兰氏阳性人体共生菌和病原体,通常被认为是龋齿的主要致病因素。该菌株的代谢活动会产生酸,其分泌产物被认为是致病因素以及通过刺激促炎细胞因子释放来促进免疫调节的因子。来自人类微生物组的微生物次生代谢途径的产物因其免疫调节功能而受到越来越多的研究。在本研究中,我们试图利用系统代谢组学方法探索变形链球菌模式菌株变形链球菌UA159中非核糖体肽途径的代谢组输出,以深入分析该生物体产生的产物,并探究这些分子的免疫调节功能。使用野生型和非核糖体肽缺失菌株(在变链菌素生物合成位点内)进行比较代谢组学和生物合成研究、前体喂养(脂肪酸衍生物),从而鉴定出58种代谢物,其中13种的结构得到了阐明。除此之外,还鉴定出了一种装配线脱轨产物变链酰胺,并用于评估变链菌素的免疫调节特性以及与其先前报道的描述白色念珠菌菌丝抑制谱的功能相关的作用。本研究结果证明了源自这一独特生物合成装配线的产物的复杂性和不同作用。

相似文献

1
Systems biosynthesis of secondary metabolic pathways within the oral human microbiome member Streptococcus mutans.口腔人类微生物群成员变形链球菌中次生代谢途径的系统生物合成。
Mol Biosyst. 2015 Jan;11(1):97-104. doi: 10.1039/c4mb00406j. Epub 2014 Sep 11.
2
Fungal biofilm inhibitors from a human oral microbiome-derived bacterium.从人类口腔微生物组衍生的细菌中分离到的真菌生物膜抑制剂。
Org Biomol Chem. 2012 Mar 14;10(10):2044-50. doi: 10.1039/c2ob06856g. Epub 2012 Jan 27.
3
Streptococcus mutans inhibits Candida albicans hyphal formation by the fatty acid signaling molecule trans-2-decenoic acid (SDSF).变形链球菌通过脂肪酸信号分子反式-2-癸烯酸(SDSF)抑制白色念珠菌菌丝形成。
Chembiochem. 2010 Jul 26;11(11):1552-62. doi: 10.1002/cbic.201000086.
4
Cariogenic Produces Tetramic Acid Strain-Specific Antibiotics That Impair Commensal Colonization.致龋菌产生的四氢酸菌株特异性抗生素会损害共生定植。
ACS Infect Dis. 2020 Apr 10;6(4):563-571. doi: 10.1021/acsinfecdis.9b00365. Epub 2020 Jan 10.
5
Genome mining unveils widespread natural product biosynthetic capacity in human oral microbe Streptococcus mutans.基因组挖掘揭示人类口腔微生物变形链球菌中广泛的天然产物生物合成能力。
Sci Rep. 2016 Nov 21;6:37479. doi: 10.1038/srep37479.
6
Interspecies competition and inhibition within the oral microbial flora: environmental factors influence the inhibition of Streptococcus mutans by Streptococcus oligofermentans.口腔微生物群中的种间竞争与抑制:环境因素对寡发酵链球菌抑制变形链球菌的影响。
Eur J Oral Sci. 2012 Jun;120(3):179-84. doi: 10.1111/j.1600-0722.2012.00957.x. Epub 2012 Apr 21.
7
Streptococcus oligofermentans inhibits Streptococcus mutans through conversion of lactic acid into inhibitory H2O2: a possible counteroffensive strategy for interspecies competition.寡发酵链球菌通过将乳酸转化为具有抑制作用的过氧化氢来抑制变形链球菌:一种种间竞争的可能反击策略。
Mol Microbiol. 2007 Feb;63(3):872-80. doi: 10.1111/j.1365-2958.2006.05546.x.
8
Two-dimensional gel-based proteomic of the caries causative bacterium Streptococcus mutans UA159 and insight into the inhibitory effect of carolacton.基于二维凝胶的致龋菌变异链球菌 UA159 的蛋白质组学研究及卡罗来酮的抑制作用研究
Proteomics. 2013 Dec;13(23-24):3470-7. doi: 10.1002/pmic.201300077. Epub 2013 Nov 20.
9
Antagonistic action of indigenous Streptococcus mutans strains.本土变形链球菌菌株的拮抗作用。
Acta Odontol Latinoam. 2009;22(2):129-38.
10
Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.抗菌十肽 KSL 对口腔病原体和变形链球菌生物膜生长的影响。
Int J Antimicrob Agents. 2011 Jan;37(1):33-8. doi: 10.1016/j.ijantimicag.2010.08.014. Epub 2010 Oct 17.

引用本文的文献

1
Synergistic action of specialized metabolites from divergent biosynthesis in the human oral microbiome.人类口腔微生物群中不同生物合成途径产生的特殊代谢产物的协同作用。
Proc Natl Acad Sci U S A. 2025 Aug 26;122(34):e2504492122. doi: 10.1073/pnas.2504492122. Epub 2025 Aug 19.
2
Streptococcal natural products mediate interspecies competition with Gram-positive bacterial pathogens.链球菌天然产物介导与革兰氏阳性病原菌的种间竞争。
bioRxiv. 2025 Jul 31:2025.07.31.667707. doi: 10.1101/2025.07.31.667707.
3
Exploring the bioactive landscape: peptides and non-peptides from the human microbiota.
探索生物活性全景:来自人类微生物群的肽类和非肽类物质
NPJ Biofilms Microbiomes. 2025 May 8;11(1):76. doi: 10.1038/s41522-025-00713-x.
4
Mutanobactin-D, a Non-Ribosomal Cyclic Lipopeptide, Induces Osteogenic/Odontogenic Differentiation of Human Dental Pulp Stem Cells and Human Bone Marrow Stem Cells.突变诺菌素-D,一种非核糖体环脂肽,可诱导人牙髓干细胞和人骨髓干细胞的成骨/成牙分化。
Int J Mol Sci. 2025 Jan 28;26(3):1144. doi: 10.3390/ijms26031144.
5
Comparative Lipidomics of Oral Commensal and Opportunistic Bacteria.口腔共生菌与机会致病菌的比较脂质组学
Metabolites. 2024 Apr 20;14(4):240. doi: 10.3390/metabo14040240.
6
Oral streptococci: modulators of health and disease.口腔链球菌:健康与疾病的调节剂。
Front Cell Infect Microbiol. 2024 Feb 22;14:1357631. doi: 10.3389/fcimb.2024.1357631. eCollection 2024.
7
[Latest Findings on Polyketides/Non-ribosomal Peptides That Are Secondary Metabolites of ].[关于作为……次生代谢产物的聚酮化合物/非核糖体肽的最新发现]。 你提供的原文似乎不完整,句末括号里的内容缺失,以上是根据现有内容翻译的。
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 May;54(3):685-691. doi: 10.12182/20230560302.
8
Diversity of the fecal microbiota in Chinese ponies.中国矮种马粪便微生物群的多样性
Front Vet Sci. 2023 Jan 26;10:1102186. doi: 10.3389/fvets.2023.1102186. eCollection 2023.
9
Total Synthesis of Mutanobactins A, B from the Human Microbiome: Macrocyclization and Thiazepanone Assembly in a Single Step.从人体微生物组中全合成突变杆菌素 A、B:一步中环化和噻唑烷酮组装。
Angew Chem Int Ed Engl. 2022 Jul 11;61(28):e202203051. doi: 10.1002/anie.202203051. Epub 2022 Jun 10.
10
Microbial metabolites: cause or consequence in gastrointestinal disease?微生物代谢产物:在胃肠道疾病中是原因还是结果?
Am J Physiol Gastrointest Liver Physiol. 2022 Jun 1;322(6):G535-G552. doi: 10.1152/ajpgi.00008.2022. Epub 2022 Mar 10.